1. Home
  2. UG vs BOLD Comparison

UG vs BOLD Comparison

Compare UG & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UG
  • BOLD
  • Stock Information
  • Founded
  • UG 1942
  • BOLD 2018
  • Country
  • UG United States
  • BOLD United States
  • Employees
  • UG N/A
  • BOLD N/A
  • Industry
  • UG Package Goods/Cosmetics
  • BOLD
  • Sector
  • UG Consumer Discretionary
  • BOLD
  • Exchange
  • UG Nasdaq
  • BOLD Nasdaq
  • Market Cap
  • UG 36.8M
  • BOLD 30.3M
  • IPO Year
  • UG N/A
  • BOLD 2024
  • Fundamental
  • Price
  • UG $8.03
  • BOLD $1.50
  • Analyst Decision
  • UG
  • BOLD Hold
  • Analyst Count
  • UG 0
  • BOLD 1
  • Target Price
  • UG N/A
  • BOLD N/A
  • AVG Volume (30 Days)
  • UG 12.8K
  • BOLD 63.1K
  • Earning Date
  • UG 05-08-2025
  • BOLD 05-16-2025
  • Dividend Yield
  • UG 8.72%
  • BOLD N/A
  • EPS Growth
  • UG 4.82
  • BOLD N/A
  • EPS
  • UG 0.63
  • BOLD N/A
  • Revenue
  • UG $11,408,154.00
  • BOLD N/A
  • Revenue This Year
  • UG N/A
  • BOLD N/A
  • Revenue Next Year
  • UG N/A
  • BOLD N/A
  • P/E Ratio
  • UG $11.28
  • BOLD N/A
  • Revenue Growth
  • UG N/A
  • BOLD N/A
  • 52 Week Low
  • UG $7.73
  • BOLD $1.06
  • 52 Week High
  • UG $16.25
  • BOLD $12.26
  • Technical
  • Relative Strength Index (RSI)
  • UG 41.60
  • BOLD N/A
  • Support Level
  • UG $7.85
  • BOLD N/A
  • Resistance Level
  • UG $8.44
  • BOLD N/A
  • Average True Range (ATR)
  • UG 0.39
  • BOLD 0.00
  • MACD
  • UG 0.03
  • BOLD 0.00
  • Stochastic Oscillator
  • UG 22.14
  • BOLD 0.00

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: